Allergan can't delay shareholder vote on hostile Valeant bid

Valeant Pharmaceuticals and Pershing Square Capital Management reportedly plan to ask Allergan for a shareholder vote on their hostile takeover attempt, after a federal judge rules that Allergan's insider trading lawsuit won't delay the meeting.

Pershing Square Capital Management, Valeant Pharmaceuticals, Allergan Inc.

Legal News, News Well, Mergers & Acquisitions, Pharmaceuticals, Wall Street Beat

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/YISIo7